Aurinia to Host R&D Day and Webcast on October 20th in New York, NY
20 September 2017 - 6:01AM
Business Wire
Presentations will highlight strategy to expand
voclosporin’s opportunity in novel indications
Aurinia Pharmaceuticals Inc., (NASDAQ: AUPH / TSX: AUP) today
announced that it will host an R&D Day on October 20, 2017 at
8:00am Eastern Time in New York, NY. Members of the Aurinia
leadership team and external opinion leaders will provide R&D
and commercial insights for voclosporin in lupus nephritis and new
additional indications.
The agenda for the meeting is as follows:
8:00 a.m. – 8:30 a.m. ET – Breakfast8:30 a.m. – 10:45 a.m. ET –
Presentations10:45 a.m. – 11:30 a.m. ET – Q&A
The event is intended for institutional investors, sell-side
analysts, investment bankers and business development
professionals only. Please RSVP in advance if you plan to attend,
as space is limited. To reserve a spot, please send an email to
IR@auriniapharma.com. A live webcast of the event, with slides,
will be available on the Investors section of the Company’s website
at http://ir.auriniapharma.com/ir-calendar.
About AuriniaAurinia is a clinical stage
biopharmaceutical company focused on developing and commercializing
therapies to treat targeted patient populations that are suffering
from serious diseases with a high unmet medical need. The company
is currently developing voclosporin, an investigational drug, for
the treatment of LN. The company is headquartered in Victoria, BC
and focuses its development efforts globally.
www.auriniapharma.com.
We seek safe harbor.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170919006588/en/
Aurinia Pharmaceuticals Inc.Investor Contact:Celia
EconomidesVP, Corporate & Public
Affairsceconomides@auriniapharma.comorMedia:Christopher
Hippolyte, 212-364-0458Christopher.hippolyte@inventivhealth.com
Aurinia Pharmaceuticals (NASDAQ:AUPH)
Historical Stock Chart
From Apr 2024 to May 2024
Aurinia Pharmaceuticals (NASDAQ:AUPH)
Historical Stock Chart
From May 2023 to May 2024